Maxima Medisch Centrum — Clinical Trial Site

79 Registered trials

37 Currently recruiting

Organisation

Maxima Medisch Centrum

Location

Veldhoven, Netherlands

Identifier

ORG-100043866

Address

Ds Theodor Fliednerstraat 1, 5631 BM, Netherlands

Departments

-
#4003: Cardiology
Afd. Hematologie
Cardiology
Cardiology Department
Chirurgie
Department of Dermatology
Department of Medical Oncology
Dpt of Medical Oncology
Emergency Department
Endocrinologie
gynaecolgie
Gynaecology
Hematologie
Hematology
IC Neonatology
ICU
Internal Medicine
Interne Geneeskunde
Longgeneeskunde
Lung/Oncology
Maxima MC, locatie Veldhoven
Maxima Oncologisch Centrum
Medical oncology
N/A
Obstetrics & Gynaeccology
Obstetrics & Gynecology
Oncologie
Oncology
Pulmonology
Reproductive medicine and gynecology
Surgery
urology
Verloskunde & Gynaecologie

Clinical trials at this site (79)

Search interface

Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
Does progesterone luteal‑phase support increase live birth rates in couples with unexplained infertility assigned to expectant management? Pending

2026-525747-33-00 unexplained subfertillity, infertillity 6
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
T3-4-Hypo trial Recruiting

2024-513883-24-00 Hypothyroidism Triiodothyronine Quality of Life Persist 5 2025-11-02
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
Selective Treatment of Oral Povorcitinib in Prurigo Nodularis Study 1 (STOP-PN1) Recruiting

2024-511879-16-00 Prurigo Nodularis 5 2024-12-12
COLLISION RELAPSE trial Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospect… Recruiting

2024-515341-41-01 Colorectal liver metastases 11 2024-12-11
Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment Recruiting

2023-507481-43-00 Solid tumors 11 2024-06-25
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Ca… Recruiting

2022-501703-27-00 Advanced or Metastatic Non-Clear Cell Renal Cell Carcin 5 2023-07-05
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Recruiting

2023-506194-35-00 Colorectal liver metastases 5 2026-05-22
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
Optimization of pain management for acute renal colic in the Emergency Department – The OPTIMIZED trial Recruiting

2025-521316-19-00 Urolithiasis 6 2026-04-20
Neoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait A… Recruiting

2025-523692-39-00 locally advanced rectal cancer 5 2026-03-11
A Phase 2/3 clinical trial with zanzalintinib versus everolimus Recruiting

2025-521043-20-00 Neuroendocrine tumors 10 2026-01-27
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting

2025-520518-79-00 Atrial Fibrillation 4 2026-01-06
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation. Recruiting

2025-521377-14-00 Atrial fibrillation 4 2025-10-06
Metformin for the prolongation of pregnancy in preterm preeclampsia: the PI-NL trial Recruiting

2023-510382-10-00 HELLP syndrome 5 2025-08-25
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
Laparoscopic Antibiotic Lavage to Prevent intra-abdominal Abscess formation in Complicated Appendicitis (ALPACA) Recruiting

2024-514850-59-00 Appendicitis 5 2025-02-24
A global phase III study to investigate the effectiveness and safety of rilvegostomig plus chemotherapy to that of pembrolizumab plus chemot… Recruiting

2024-514281-39-00 Metastatic Squamous Non-small Cell Lung Cancer Whose Tu 5 2025-02-14
A global phase III study to investigate the effectiveness and safety of Rilvegostomig plus chemotherapy to that of pembrolizumab plus chemot… Recruiting

2024-515008-38-00 Metastatic Non-squamous Non-small Cell Lung Cancer Whos 5 2025-02-14
Safe Stop Trial Melanoma Recruiting

2024-516937-10-01 Melanoma 5 2024-12-18